- 米国企業
- Cerevel Therapeutics Holdings, Inc.
Cerevel Therapeutics Holdings, Inc.CERE
時価総額
$81.1億
PER
2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
Cash and cash equivalents | 384 | 193 | 137 |
Marketable securities | - | 373 | 756 |
Prepaid expenses and other current assets | 7 | 12 | 14 |
Total current assets | 391 | 578 | 906 |
Marketable securities | - | 52 | 58 |
Property and equipment, net | 24 | 28 | 27 |
Operating lease assets | 24 | 23 | 22 |
Restricted cash | 4 | 4 | 2 |
Other long-term assets | - | - | 3 |
Total assets | 445 | 689 | 1,018 |
Accounts payable | 5 | 11 | 10 |
Accrued Liabilities and Other Liabilities | 23 | 29 | 60 |
Operating Lease, Liability, Current | 2 | 2 | 3 |
Total current liabilities | 30 | 43 | 73 |
Operating Lease, Liability, Noncurrent | 31 | 34 | 31 |
Noncurrent Financing Liability Related Party | - | 17 | 29 |
Noncurrent Financing Liability | - | 17 | 29 |
Convertible Debt, Noncurrent | - | - | 335 |
Other long-term liabilities | 0 | 0 | - |
Total liabilities | 61 | 110 | 497 |
Common Stock, Value, Issued | 0 | 0 | 0 |
Additional paid-in capital | 775 | 1,196 | 1,486 |
Accumulated other comprehensive income (loss) | - | -1 | 3 |
Accumulated deficit | -391 | -616 | -968 |
Total stockholders’ equity | 385 | 579 | 521 |
Total liabilities and stockholders’ equity | 445 | 689 | 1,018 |